These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 38473009)

  • 1. Diagnosis, Management, and Prognosis of Cystic Fibrosis-Related Liver Disease in Children.
    Anton-Păduraru DT; Azoicăi AN; Trofin F; Murgu AM; Mîndru DE; Bocec AS; Halițchi COI; Zota GR; Păduraru D; Nastase EV
    Diagnostics (Basel); 2024 Mar; 14(5):. PubMed ID: 38473009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and Management of Gastrointestinal Manifestations in Children with Cystic Fibrosis.
    Anton-Păduraru DT; Murgu AM; Bozomitu LI; Mîndru DE; Iliescu Halițchi CO; Trofin F; Ciongradi CI; Sârbu I; Eṣanu IM; Azoicăi AN
    Diagnostics (Basel); 2024 Jan; 14(2):. PubMed ID: 38275475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis related liver disease and endocrine considerations.
    Sherwood JS; Ullal J; Kutney K; Hughan KS
    J Clin Transl Endocrinol; 2022 Mar; 27():100283. PubMed ID: 35024343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic Fibrosis Liver Disease: Know More.
    Al Sinani S; Al-Mulaabed S; Al Naamani K; Sultan R
    Oman Med J; 2019 Nov; 34(6):482-489. PubMed ID: 31745411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis-related liver disease is an independent risk factor for mortality and increased health care resource utilization in hospitalized pediatric patients with cystic fibrosis.
    Thavamani A; Umapathi KK; Kutney K; Sferra TJ; Sankararaman S
    Pediatr Pulmonol; 2022 Jul; 57(7):1717-1725. PubMed ID: 35499220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and genetic risk factors for cystic fibrosis-related liver disease in Egyptian CF children: A single-center experience.
    El-Faramawy A; Nasr SZ; Emam MMSA; Fahmy HMH
    Pediatr Pulmonol; 2024 Feb; 59(2):465-471. PubMed ID: 38038166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis-associated liver disease in children.
    Wasuwanich P; Karnsakul W
    Minerva Pediatr; 2020 Oct; 72(5):440-447. PubMed ID: 32418413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver disease in cystic fibrosis.
    Kobelska-Dubiel N; Klincewicz B; Cichy W
    Prz Gastroenterol; 2014; 9(3):136-41. PubMed ID: 25097709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools.
    Scott JA; Jones AM; Jokl E; Gordon-Walker T; Barry PJ; Hanley NA; Piper Hanley K; Athwal VS
    Heliyon; 2023 Nov; 9(11):e21861. PubMed ID: 38053913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of CFTR mutations in people with cystic fibrosis and severe liver disease who are not eligible for CFTR modulators.
    Colombo C; Ramm GA; Lindblad A; Corti F; Porcaro L; Alghisi F; Asherova I; Evans H; Kashirskaya N; Kondratyeva E; Lewindon PJ; de Monestrol I; Oliver M; Ooi CY; Padoan R; Shankar S; Alicandro G
    J Cyst Fibros; 2023 Mar; 22(2):263-265. PubMed ID: 36739240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis liver disease in Newfoundland and Labrador: a prevalence study.
    Squirell E; Lockyer J
    Can Liver J; 2021; 4(1):33-37. PubMed ID: 35991469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis rabbits develop spontaneous hepatobiliary lesions and CF-associated liver disease (CFLD)-like phenotypes.
    Wu Q; Liang X; Hou X; Song Z; Bouhamdan M; Qiu Y; Koike Y; Rajagopalan C; Wei HG; Jiang H; Hish G; Zhang J; Chen YE; Jin JP; Xu J; Zhang K; Sun F
    PNAS Nexus; 2023 Jan; 2(1):pgac306. PubMed ID: 36712930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies.
    Dana J; Debray D; Beaufrère A; Hillaire S; Fabre M; Reinhold C; Baumert TF; Berteloot L; Vilgrain V
    J Hepatol; 2022 Feb; 76(2):420-434. PubMed ID: 34678405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and characteristics of cystic fibrosis liver disease: a study highlighting the lack of histological diagnosis.
    Issa Z; Gohy S; Zech F; Baldin P; Delire B; Dahlqvist G
    Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):101977. PubMed ID: 35772685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores.
    Karlas T; Neuschulz M; Oltmanns A; Güttler A; Petroff D; Wirtz H; Mainz JG; Mössner J; Berg T; Tröltzsch M; Keim V; Wiegand J
    PLoS One; 2012; 7(7):e42139. PubMed ID: 22848732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric Cystic Fibrosis.
    Calvopina DA; Lewindon PJ; Ramm LE; Noble C; Hartel GF; Leung DH; Ramm GA
    J Cyst Fibros; 2022 Mar; 21(2):236-242. PubMed ID: 34953741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs as noninvasive diagnostic biomarkers of liver disease in children with cystic fibrosis.
    Cook NL; Pereira TN; Lewindon PJ; Shepherd RW; Ramm GA
    J Pediatr Gastroenterol Nutr; 2015 Feb; 60(2):247-54. PubMed ID: 25625579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Treatment Options for Cystic Fibrosis-Related Liver Disease.
    Staufer K
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis.
    Scott J; Jones AM; Piper Hanley K; Athwal VS
    Aliment Pharmacol Ther; 2022 Feb; 55(4):389-400. PubMed ID: 35048397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.